A New Homogeneous Surrogate Virus Neutralization Test Format Based on Liposomes and the Complement System

Abstract Neutralizing antibodies are key mediators of protection against common viral infections such as SARS-CoV-2, influenza and respiratory syncytial virus (RSV), making them an important target for diagnostic assays assessing immune status and vaccine efficacy. Here we present a novel platform technology that specifically detects SARS-CoV-2 neutralizing antibodies in a simple homogeneous no-wash format as a surrogate virus neutralization test (sVNT). Liposomes loaded with a quenched fluorophore were modified with the angiotensin-converting enzyme 2 (ACE2) receptor, the main receptor for SARS-CoV-2 entry. Virus surrogates based on the receptor binding domain (RBD) of the SARS-CoV-2 spike protein were developed that bind to ACE2-liposomes and contain a trigger moiety, which activates the complement system leading to liposome lysis. Neutralizing antibodies inhibit this binding event and thus prevent the generation of a fluorescent signal. The proof-of-principle was demonstrated using SARS-CoV-2 neutralizing antibodies and pooled human serum, generating IC50 values that can be compared to other assay formats. Testing of 20 SARS-CoV-2 antibody negative sera and 24 sera from individuals with SARS-CoV-2 infection and/or vaccination history, resulted in a specificity of 95%, sensitivity of 96% and a strong correlation (Spearman r = 0.78, Pearson r = 0.77) with antibody titers determined in a pseudovirus neutralization test. The assay platform can be readily adapted to other targets, offering a rapid and straightforward approach to serological immunodiagnostics and in general other competitive assay formats. The simplicity of the assay, the avoidance of washing and immobilization steps renders this format ideally suited for high-throughput screening and point-of-care settings.

Authors

Institutions

Publication Details

Journal
Analytical Chemistry
Published
2026-11-16
DOI
https://doi.org/10.1021/acs.analchem.6c04398
Primary Topic
SARS-CoV-2 detection and testing
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A New Homogeneous Surrogate Virus Neutralization Test Format Based on Liposomes and the Complement System

Miriam Breunig, Simon Streif, Kilian Hoecherl, Sebastian Einhauser et al.
1 links
Analytical Chemistry
SARS-CoV-2 detection and testing
article

A New Homogeneous Surrogate Virus Neutralization Test Format Based on Liposomes and the Complement System

Miriam Breunig, Simon Streif, Kilian Hoecherl, Sebastian Einhauser, Diana Pauly, Jens Konrad, Antje J. Baeumner, Christina Reiner, Patrick Neckermann, Ralf Wagner
article en

Abstract

Abstract Neutralizing antibodies are key mediators of protection against common viral infections such as SARS-CoV-2, influenza and respiratory syncytial virus (RSV), making them an important target for diagnostic assays assessing immune status and vaccine efficacy. Here we present a novel platform technology that specifically detects SARS-CoV-2 neutralizing antibodies in a simple homogeneous no-wash format as a surrogate virus neutralization test (sVNT). Liposomes loaded with a quenched fluorophore were modified with the angiotensin-converting enzyme 2 (ACE2) receptor, the main receptor for SARS-CoV-2 entry. Virus surrogates based on the receptor binding domain (RBD) of the SARS-CoV-2 spike protein were developed that bind to ACE2-liposomes and contain a trigger moiety, which activates the complement system leading to liposome lysis. Neutralizing antibodies inhibit this binding event and thus prevent the generation of a fluorescent signal. The proof-of-principle was demonstrated using SARS-CoV-2 neutralizing antibodies and pooled human serum, generating IC50 values that can be compared to other assay formats. Testing of 20 SARS-CoV-2 antibody negative sera and 24 sera from individuals with SARS-CoV-2 infection and/or vaccination history, resulted in a specificity of 95%, sensitivity of 96% and a strong correlation (Spearman r = 0.78, Pearson r = 0.77) with antibody titers determined in a pseudovirus neutralization test. The assay platform can be readily adapted to other targets, offering a rapid and straightforward approach to serological immunodiagnostics and in general other competitive assay formats. The simplicity of the assay, the avoidance of washing and immobilization steps renders this format ideally suited for high-throughput screening and point-of-care settings.

Analytical Chemistry
Philipps University of Marburg (DE), University Hospital Regensburg (DE), University of Regensburg (DE)
Bundesministerium für Bildung und Forschung, Bayerisches Staatsministerium für Wissenschaft und Kunst
Good health and well-being
SARS-CoV-2 detection and testing
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon